Current prostate cancer treatment: Not what but when?

Affiliations

Peter A Massaro et al. Can Urol Assoc J. 2016 Aug.

. 2016 Aug;10(7-8):251-252.

doi: 10.5489/cuaj.4018.

No abstract available

Comment on

A comparative study of radical prostatectomy and permanent seed brachytherapy for low- and intermediate-risk prostate cancer.
Taussky D, Ouellet V, Delouya G, Saad F. Taussky D, et al. Can Urol Assoc J. 2016 Aug;10(7-8):246-250. doi: 10.5489/cuaj.3537. Can Urol Assoc J. 2016. PMID: 27878044 Free PMC article.

1. Wolff RF, Ryder S, Bossi A, et al. A systematic review of randomized, controlled trials of radiotherapy for localized prostate cancer. Eur J Cancer. 2015;51:2345–67. doi: 10.1016/j.ejca.2015.07.019. - DOI - PubMed
1. Eriksson D, Stigbrand T. Radiation-induced cell death mechanisms. Tumour Biol. 2010;31:363–72. doi: 10.1007/s13277-010-0042-8. - DOI - PubMed
1. Toussi A, Stewart-Merrill SB, Boorjian SA, et al. Standardizing the definition of biochemical recurrence after radical prostatectomy: What prostate-specific antigen cut point best predicts a durable increase and subsequent systemic progression? J Urol. 2016;195:1754–9. doi: 10.1016/j.juro.2015.12.075. - DOI - PubMed
1. Kuban DA, Levy LB, Potters L, et al. Comparison of biochemical failure definitions for permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2006;65:1487–93. doi: 10.1016/j.ijrobp.2006.03.027. - DOI - PubMed
1. American Society for Therapeutic Radiology and Oncology Consensus Panel Consensus statement: Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys. 1997;37:1035–41. - PubMed